Drug Target Review: Transforming Cancer Treatment for Greatest Impact

In this Q&A with Drug Target Review, Dr Lev Becker, Associate Professor, University of Chicago and Cofounder of Onchilles Pharma, reveals how the company is directing research into neutrophil biology to create new therapeutics for cancer patients that need it most.

Read the article below or download the article by clicking here.